Integrative Therapy in Alcoholism
Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents
Sponsor: German Addiction Research Network
Listed as NCT00159107, this PHASE4 trial focuses on Alcoholism and remains completed. Sponsored by German Addiction Research Network, it has been updated 7 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Study Description(click to expand)The objective of this multi-center study is to optimize the long-term treatment of patients with alcohol dependence. This investigation should contribute to the issue of effective relapse prevention. Each treatment condition is lasting 6 months: a) Behavior Group Therapy + Acamprosate, b) Behavior Group Therapy + Placebo and c) support and counseling + Acamprosate. Follow-up examinations carried out 3 and 6 months after the end of treatment.
The objective of this multi-center study is to optimize the long-term treatment of patients with alcohol dependence. This investigation should contribute to the issue of effective relapse prevention. Each treatment condition is lasting 6 months: a) Behavior Group Therapy + Acamprosate, b) Behavior Group Therapy + Placebo and c) support and counseling + Acamprosate. Follow-up examinations carried out 3 and 6 months after the end of treatment.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jun 2022 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jun 2022 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
May 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- German Addiction Research Network
- German Federal Ministry of Education and Research
- Heinrich-Heine University, Duesseldorf
- Merck Sharp & Dohme LLC
- Psychosomatic Clinic of Bergisch Gladbach
- University of Bonn
- University of Homburg
- Universität Duisburg-Essen
For direct contact, visit the study record on ClinicalTrials.gov .